Determination of a quantitative relationship between hepatic CYP3A5*1/*3 and CYP3A4 expression for use in the prediction of metabolic clearance in virtual populations-Reference-Cited by-同舟云学术

Determination of a quantitative relationship between hepatic CYP3A5*1/*3 and CYP3A4 expression for use in the prediction of metabolic clearance in virtual populations

Published:2010-11 Issue:8-9 Volume:31 Page:516-532
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Barter Z. E.,Perrett H. F.,Yeo K. Rowland,Allorge D.,Lennard M. S.,Rostami-Hodjegan A.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bdd.732/fullpdf

Reference54 articles.

1. Application of computer-aided pharmacokinetic and pharmacodynamic methods from drug discovery through registration;Dong;Current Computer-Aided Drug Design,2008

2. Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors;Proctor;Xenobiotica,2004

3. A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of ‘bottom-up’ vs ‘top-down’ recognition of covariates;Jamei;Drug Metab Pharmacokinet,2009

4. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism;Lin;Mol Pharmacol,2002

5. Developmental expression of human hepatic CYP2C9 and CYP2C19;Koukouritaki;J Pharmacol Exp Ther,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically-based pharmacokinetic modelling to investigate the effect of CYP3A4/3A5 maturation on tacrolimus pharmacokinetics in paediatric HSCT patients;European Journal of Pharmaceutical Sciences;2024-10

2. Individual dose recommendations for drug interaction between tacrolimus and voriconazole in adult liver transplant recipients: A semiphysiologically based population pharmacokinetic modeling approach;European Journal of Pharmaceutical Sciences;2023-05

3. The Interplay Between Drug Release and Intestinal Gut‐Wall Metabolism;Oral Drug Delivery for Modified Release Formulations;2022-04-08

4. Extrapolation of physiologically based pharmacokinetic model for tacrolimus from renal to liver transplant patients;Drug Metabolism and Pharmacokinetics;2022-02

5. Investigation of the Impact of CYP3A5 Polymorphism on Drug–Drug Interaction between Tacrolimus and Schisantherin A/Schisandrin A Based on Physiologically-Based Pharmacokinetic Modeling;Pharmaceuticals;2021-02-27